Find your path to Elisabeth
672 people in our graph share verified history with Elisabeth — schools, employers, funds. One of them is your warm intro.
Nic LowdenunlockedElisabeth: together at Credit Suisse (2013)
×2Elisabeth: together at Nomura
×4Elisabeth: together at Jefferies
Elisabeth: together at Bluebird Bio
Executive at Dewpoint Therapeutics
Intro paths
→
In turn, Elisabeth can intro founders to Dewpoint Therapeutics's investors below.
Dewpoint Therapeutics's investors · 12
3E Bioventures CapitalPalo Alto · since 20226 Dimensions CapitalGrand CaymanARCH Venture PartnersChicago · $50K – $250M checks · since 2022EcoR1 CapitalSan Francisco · since 2022General CatalystSan Francisco · $30M checks · since 2022Innovation EndeavorsPalo Alto · $1M – $15M checksLeaps by BayerLeverkusen · since 2022Maverick VenturesSan Francisco · $3M – $10M checks · since 2022Mubadala CapitalAbu Dhabi · $1M – $50M checks · since 2022Polaris PartnersBoston · $500K – $5M checks · since 2022Samsara BioCapitalPalo Alto · since 2022SoftBank Vision FundLondon
.png)
Co-founders at Dewpoint Therapeutics
RY
Richard Young, Ph.D.Director
AH
Anthony Hyman, Ph.D.Director
TH
Tony HymanScientific Co-founder
RY
Rick YoungScientific Co-founder
Experience
- PrileniaChief Financial Officercurrent2026 — present
- Autolus TherapeuticsBoard of Directors and Audit Committee Membercurrent2023 — presentLondon, England, United Kingdom
- Women In BioExecutive Women in Bio 2019 Board Room Ready Membercurrent2019 — present
- Dewpoint TherapeuticsChief Financial Officer & Corporate Development Officer2024 — 2025Boston, MA
- bluebird bioBoard of Directors and Audit Committee Chair2021 — 2025
- Atsena TherapeuticsChief Financial Officer & Chief Business Officer2022 — 2023
- Decibel TherapeuticsChief Financial Officer & Head of Corporate Development2020 — 2022
- Fortress BiotechSenior Vice President, Head of Corporate Development2016 — 2019
- NomuraExecutive Director, Healthcare Investment Banking2013 — 2016New York, New York
- Credit SuisseVice President, Healthcare Investment Banking2011 — 2013New York, New York
- JefferiesAssociate, Healthcare Investment Banking2009 — 2011New York, New York
- UBSAssociate Director, Healthcare Investment Banking2007 — 2009New York, New York
Skills & more
ValuationInvestment BankingBiotechnologyCorporate DevelopmentMergersFinancial ModelingHealthcareDue DiligenceMergers & AcquisitionsBusiness StrategyNegotiationStrategy
+3 more
LBOEquitiesCompetitive AnalysisFrom Elisabeth's professional profile.
Frequently asked questions
- Who is Elisabeth Leiderman?
- Executive Officer at Dewpoint Therapeutics
- Where does Elisabeth Leiderman work?
- Elisabeth Leiderman is Executive at Dewpoint Therapeutics.
- Where did Elisabeth Leiderman go to school?
- Elisabeth Leiderman studied at The Wharton School (MBA, Finance and Healthcare Management); American Medical Program Tel Aviv University (MD, Medicine); University of Pennsylvania (BA, Biological Sciences).
Same school
Also attended The Wharton School2,000
Sarah GuoFounder & General Partner of ConvictionJosh KopelmanFounder and Partner at First Round CapitalAydin SenkutFounder & Managing Partner at FelicisJack AbrahamFounder, CEO & Managing Partner of AtomicKatie RiesterPartner, Head of Investor Relations at Felicis VenturesTrevor OelschigInvestment Team at General Catalyst
+ 1,994 more
Also attended University of Pennsylvania1,415
Brian ActonCo-founder of WhatsApp; co-founder of Signal FoundationKunal BahlCo-founder of Snapdeal; co-founder of Titan CapitalDasha MaggioPartner at Felicis Ventures, writer on venture capital and founder psychologyNancy WangInvestor at Felicis VenturesLeah von SiemensPartner at Manta Ray VenturesEghosa OmoiguiFounder and Managing General Partner at EchoVC Partners
+ 1,409 more
Shared employers
Also worked at Women In Bio8
Chaya PatelPrincipal at Mission BiocapitalSun AltbachSenior Scientific Advisor at BOLD LongevityMonica BerrondoPhD at Brazen CapitalStar CunninghamFounder at 4D HealthwareAnna Lisa SomeraExecutive Officer at RhaeosSumita RayExecutive Officer at Cue Biopharma
+ 2 more
Also worked at bluebird bio15
Danielle AbdelahadInvestor at Third Rock VenturesAbe BassanPrincipal at Samsara BioCapitalCharlotte Jones-BurtonPartner at 2Flo VenturesPhilip ReillyVenture Partner at Third Rock VenturesAaron EdwardsFounder at KiraGen BioRyan Murray, PhDFounder at KiraGen Bio
+ 9 more
Also worked at Decibel Therapeutics6
John KeiltyVenture Partner at Third Rock VenturesChristina IsacsonPartner at Lightstone VenturesDr. Jens EcksteinAdvisor at Apollo Health VenturesMatthew KapustaFounder at UniqurePaula CobbExecutive Officer at Affinia TherapeuticsErik LarsenSenior Vice President, Clinical Development & Customer Success at Sondehealth
